Genesis Biopharma names Bishop executive chairman

Friday, March 23, 2012 03:12 PM

Genesis Biopharma, a biotechnology company developing targeted cancer immunotherapies, appointed Hans E. Bishop executive chairman of the company's board of directors.

Bishop, who was promoted from director of Genesis Biopharma, most recently served as COO of Dendreon, with responsibility for a number of operational areas of the business including manufacturing and commercial operations. He has also held high positions in Bayer Healthcare and Chiron.

"The addition of Hans as our executive chair further enhances this dynamic team as he is a proven leader with an impressive track record of enhancing operational and financial results,” said Anthony Cataldo, former executive chairman.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs